Supplementary data.docx (14.66 MB)
Download file

Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis: Supplementary data

Download (14.66 MB)
posted on 03.06.2022, 12:00 authored by Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, Chi Yi Wong, Harikrishnaa Ba Ramaraju, Oswin Chang, Thanansayan Dhivagaran, Zachary Silver

Aim: To evaluate the efficacy and safety of corticosteroids for treating hospitalized COVID-19 patients.

Materials & methods: Efficacy outcomes included time to negative SARS-CoV-2 tests, length of

stay, duration and incidence of intensive unit care stay, incidence of mortality and duration and

incidence of mechanical ventilation. Safety outcomes included the incidence of adverse events and

severe adverse events, incidence of hyperglycemia and incidence of nosocomial infections. Results:

Ninety-five randomized controlled trials (RCTs) and observational studies (n = 42,205) were included.

Corticosteroids were associated with increased length of stay (based on RCT only), increased time

to negative tests, decreased length of mechanical ventilation and increased odds of hyperglycemia.

Conclusion: Corticosteroids should be considered in patients requiring mechanical ventilation, and

glycemic monitoring may be needed when administering corticosteroids.